High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification

[1]  E. Génin,et al.  NGS mismapping confounds the clinical interpretation of the PRSS1 p.Ala16Val (c.47C>T) variant in chronic pancreatitis , 2021, Gut.

[2]  J. Rommens,et al.  Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth , 2021, Genetics in Medicine.

[3]  J. Rommens,et al.  LocusFocus: Web-based colocalization for the annotation and functional follow-up of GWAS , 2020, PLoS Comput. Biol..

[4]  M. Lerch,et al.  Next generation sequencing pitfalls in diagnosing trypsinogen (PRSS1) mutations in chronic pancreatitis , 2020, Gut.

[5]  Shan-Shan Dong,et al.  LDBlockShow: a fast and convenient tool for visualizing linkage disequilibrium and haplotype blocks based on variant call format files , 2020, bioRxiv.

[6]  Yong Wang,et al.  Ultralow-input single-tube linked-read library method enables short-read second-generation sequencing systems to routinely generate highly accurate and economical long-range sequencing information , 2020, Genome research.

[7]  L. Strug,et al.  The CFTR Mutation c.3453G > C (D1152H) Confers an Anion Selectivity Defect in Primary Airway Tissue that Can be Rescued by Ivacaftor , 2020, Journal of personalized medicine.

[8]  B. Ji,et al.  Transgenic expression of human PRSS2 exacerbates pancreatitis in mice , 2020, Gut.

[9]  Matthew R. Robinson,et al.  Accurate, scalable and integrative haplotype estimation , 2019, Nature Communications.

[10]  Christopher D. Brown,et al.  The GTEx Consortium atlas of genetic regulatory effects across human tissues , 2019, Science.

[11]  Benedict Paten,et al.  Sequence tube maps: making graph genomes intuitive to commuters , 2019, Bioinform..

[12]  Chunlin Xiao,et al.  An open resource for accurately benchmarking small variant and reference calls , 2019, Nature Biotechnology.

[13]  J. Rommens,et al.  Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci , 2019, PLoS genetics.

[14]  Mark Gerstein,et al.  GENCODE reference annotation for the human and mouse genomes , 2018, Nucleic Acids Res..

[15]  William Jones,et al.  Variation graph toolkit improves read mapping by representing genetic variation in the reference , 2018, Nature Biotechnology.

[16]  L. Strug,et al.  Recent advances in developing therapeutics for cystic fibrosis. , 2018, Human molecular genetics.

[17]  Deanna M. Church,et al.  Resolving the Full Spectrum of Human Genome Variation using Linked-Reads , 2017, bioRxiv.

[18]  Matthias Zytnicki,et al.  mmquant: how to count multi-mapping reads? , 2017, BMC Bioinformatics.

[19]  M. Sahin-Tóth,et al.  Genetic Risk in Chronic Pancreatitis: The Trypsin-Dependent Pathway , 2017, Digestive Diseases and Sciences.

[20]  D. Meyerholz,et al.  Pancreatic pathophysiology in cystic fibrosis , 2016, The Journal of pathology.

[21]  Emmanouil T. Dermitzakis,et al.  Fast and efficient QTL mapper for thousands of molecular phenotypes , 2015, bioRxiv.

[22]  E. Génin,et al.  Identification of a functional PRSS1 promoter variant in linkage disequilibrium with the chronic pancreatitis-protecting rs10273639 , 2015, Gut.

[23]  Lisa J Strug,et al.  Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene , 2015, Genetics in Medicine.

[24]  Timothy A Thornton,et al.  Robust Inference of Population Structure for Ancestry Prediction and Correction of Stratification in the Presence of Relatedness , 2015, Genetic epidemiology.

[25]  Garry R. Cutting,et al.  Cystic fibrosis genetics: from molecular understanding to clinical application , 2014, Nature Reviews Genetics.

[26]  G. Heijne,et al.  Inefficient SRP Interaction with a Nascent Chain Triggers a mRNA Quality Control Pathway , 2014, Cell.

[27]  J. Rommens,et al.  Genetic Modifiers of Cystic Fibrosis–Related Diabetes , 2013, Diabetes.

[28]  George P Patrinos,et al.  Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene , 2013, Nature Genetics.

[29]  Robert C. Green,et al.  Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis , 2012, Nature Genetics.

[30]  P. Durie,et al.  Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[31]  Michael R Knowles,et al.  Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis , 2012, Nature Genetics.

[32]  Heng Li,et al.  A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data , 2011, Bioinform..

[33]  B. Browning,et al.  Haplotype phasing: existing methods and new developments , 2011, Nature Reviews Genetics.

[34]  V. Bansal,et al.  The importance of phase information for human genomics , 2011, Nature Reviews Genetics.

[35]  Josyf Mychaleckyj,et al.  Robust relationship inference in genome-wide association studies , 2010, Bioinform..

[36]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[37]  Yusuke Nakamura,et al.  The Textile Plot: A New Linkage Disequilibrium Display of Multiple-Single Nucleotide Polymorphism Genotype Data , 2010, PloS one.

[38]  M. Robinson,et al.  A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.

[39]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[40]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[41]  K. Hemminki,et al.  High-throughput genotyping of a common deletion polymorphism disrupting the TRY6 gene and its association with breast cancer risk , 2007, BMC genetics.

[42]  D. Reich,et al.  Population Structure and Eigenanalysis , 2006, PLoS genetics.

[43]  M. Corey,et al.  Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening. , 2006, The Journal of pediatrics.

[44]  N. Malats,et al.  A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis , 2006, Nature Genetics.

[45]  W. Greenhalf,et al.  Clinical and genetic characteristics of hereditary pancreatitis in Europe. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[46]  J. Goldblatt,et al.  Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C. , 2001, The European respiratory journal.

[47]  C. Férec,et al.  Genes, Cloned cDNAs, and Proteins of Human Trypsinogens and Pancreatitis-Associated Cationic Trypsinogen Mutations , 2000, Pancreas.

[48]  M. Gorry,et al.  Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene , 1996, Nature Genetics.

[49]  L. Hood,et al.  The Complete 685-Kilobase DNA Sequence of the Human β T Cell Receptor Locus , 1996, Science.

[50]  J. Riordan,et al.  Identification of the Cystic Fibrosis Gene : Chromosome Walking and Jumping Author ( s ) : , 2008 .

[51]  L. Barron,et al.  Biochemical analysis of meconium in fetuses presumed to have cystic fibrosis , 1986, Prenatal diagnosis.

[52]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[53]  Pardis C Sabeti,et al.  Common deletion polymorphisms in the human genome , 2006, Nature Genetics.

[54]  H. Heijerman,et al.  Correlation between genotype and phenotype in patients with cystic fibrosis. , 1994, The New England journal of medicine.